ReviewFrontiers in pharmacology2022

Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease.

Sahar Mohajeri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.